Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 3035-3044
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.3035
Table 7 Comparison of major adverse cardiac events between the two groups, n (%)
MACE event
Control group (n = 51)
Case management unit (n = 52)
χ2/t
P value
Myocardial infarction1 (1.96)0 (0.00)
Heart failure1 (1.96)1 (1.92)
Malignant arrhythmia2 (3.92)1 (1.92)
Cardiac readmission5 (9.80)2 (3.85)
Cerebral apoplexy1 (1.96)0 (0.00)
reCABG1 (1.96)0 (0.00)
Cumulative MACE incidence11 (21.57)4 (7.69)3.9850.046